About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Proteomics in Small Cell Lung Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05623956

Proteomics in Small Cell Lung Cancer

The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.

Lead sponsor: Aalborg University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Borgen Dalsgaard

CONTACT

97606989 [email protected]

Sponsors

Lead Sponsor

Aalborg University Hospital

The study will include 50 patients with newly diagnosed SCLC, referred to systemic antineoplastic treatment at the Dept. of Oncology, Aalborg University Hospital and blood samples from 50 healthy blood donors. The blood samples from SCLC patients will be collected before chemotherapy with Carboplatin and Etoposide and after 2 cycles of chemotherapy. Imaging will be performed at the Dept. of Radiology, Aalborg University Hospital before chemotherapy and after 3 cycles of the treatment.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Written and signed informed consent
•Histopathologically and/or cytologically newly-diagnosed SCLC
•Measurable disease on CT scans
•Eligibility to receive standard chemotherapy consisting of carboplatin and etoposide

Exclusion Criteria

•Active biopsy-verified second malignancy other than non-melanoma skin cancer or cervical carcinoma in situ
•Prior treatment for any malignant diseases other than non-melanoma skin cancer and cervical carcinoma in situ
•Concomitant anticoagulation treatment (acetylsalicylic acid and clopidogrel are allowed)
•Treatment with any other investigational agent

Related studies

RECRUITINGPhase 3

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

NCT06312137 · Non Small Cell Lung Cancer

RECRUITINGPhase 2

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

NCT07444437 · Non-Small Cell Lung Cancer

RECRUITINGPhase 2

A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

NCT07489716 · Non-Small Cell Lung Cancer

RECRUITINGPhase 2

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer

RECRUITINGPhase 1

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 31, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment50

Start dateMar 2023

Last updatedJan 31, 2025

Condition

Small Cell Lung Cancer

Locations shown

Aalborg University Hospital

Aalborg, Region North Jutland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions